Back

Consistent Induction of Broadly Neutralizing HIV Antibodies by a Novel Two-Step Mechanism Informs Immunogen Design

Skelly, A. N.; Gristick, H. B.; Li, H.; Gavor, E.; Connell, A. J.; Kreider, E. F.; Marchitto, L.; Hogarty, M. P.; Newby, M. L.; Allen, J. D.; Liu, W.; West, A. P.; Ayyanathan, K.; Campion, M. S.; Winters, K.; Gordon, C. G.; Osbaldeston, R. A.; Akeley, M. J.; Li, Y.; Singh, A.; Cruickshank, K.; Park, Y.; Zhao, C.; Li, X.; Amereh, K.; Van Itallie, E.; Carey, J. W.; Albertus, A.; DeLaitsch, A. T.; Keeffe, J. R.; Lituchy, M. G.; Walsh, A. A.; Morris, D. J.; Habib, R.; Bibollet-Ruche, F.; Mishra, N.; Avillion, G.; Koranda, N. S.; Plante, S. J.; Martella, C. L.; Lora, J.; Wang, E. J. D.; Lewis, M. G

2025-10-06 immunology
10.1101/2025.10.06.680687 bioRxiv
Show abstract

A major obstacle confronting HIV-1 vaccine and cure research is the lack of an outbred animal model for rapid and consistent induction of broadly neutralizing antibodies (bNAbs). We designed an epitope-focused simian-human immunodeficiency virus (SHIV.5MUT) that elicited broad and potent V3-glycan-targeted antibodies within a year of infection in 14 of 22 macaques compared with 0 of 14 control animals. SHIV.5MUT elicited bNAbs by a novel two-step mechanism, inducing an initial wave of V1-directed antibodies that selected for Envs with shortened, hypoglycosylated V1 loops, which in turn primed V3-glycan bNAb precursors. Rhesus bNAbs were immunogenetically and structurally diverse, closely resembling human V3-glycan bNAbs. Env-bNAb coevolution revealed a diverse repertoire of bNAb precursors and the Env variants that matured them, yielding a molecular blueprint for vaccine design.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.